Ganciclovir Is Associated with Low or Undetectable Epstein-Barr Virus DNA Load in Cerebrospinal Fluid of Patients with HIV-Related Primary Central Nervous System Lymphoma
Author(s) -
Simona Bossolasco,
Kerstin I. Falk,
Maurilio Ponzoni,
N. Ceserani,
Fulvio Crippa,
Adriano Lazzarin,
Annika Linde,
Paola Cinque
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/499956
Subject(s) - ganciclovir , primary central nervous system lymphoma , cerebrospinal fluid , medicine , lymphoma , viral load , epstein–barr virus , virus , herpesviridae , cytomegalovirus , virology , gastroenterology , chemotherapy , human cytomegalovirus , immunology , viral disease
Epstein-Barr virus (EBV) is pathogenically linked to human immunodeficiency virus (HIV)-related primary central nervous system lymphoma (PCNSL) and is found in virtually all HIV-related PCNSL cases. The objective of this study was to assess the effect of ganciclovir on EBV DNA replication in patients with HIV-related PCNSL.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom